Clinical trial
Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive…
NCT00476515 · Massachusetts General Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00476515 |
|---|---|
| Title | Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor |
| Official title | Multicenter Trial Using Multi-dose Rituximab as Induction and Desensitization Therapy for Patients on the Waiting List for Kidney Transplant With a Positive Donor Specific Crossmatch to a Living Donor |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Biogen Industry Genentech, Inc. |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Kidney Insufficiency |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 0 |
| Start date | Mar 1, 2007 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | May 22, 2007 |
| Last update posted | Oct 23, 2023 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: